6 studies found for:    17321312 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
Condition: In-stent Restenosis
Interventions: Device: Coronary angioplasty using the paclitaxel-eluting balloon;   Device: Coronary angioplasty using the Everolimus-eluting stent
2 Unknown  RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
Condition: In-Stent Restenosis
Interventions: Device: Coronary angioplasty using the paclitaxel-eluting balloon;   Device: Coronary angioplasty using the everolimus-eluting stent
3 Completed Six-month Coverage and Vessel Wall Response of the Zotarolimus Drug-eluting Stent Implanted in AMI Assessed by Optical Coherence Tomography
Condition: Acute Myocardial Infarction
Interventions: Device: ENDEAVOR® drug-eluting stent (Medtronic, Santa Rosa, CA);   Device: DRIVER bare metal stent (Medtronic, Santa Rosa, Ca);   Device: Coronary stent implantation;   Device: Bare Metal Coronary Stent
4 Not yet recruiting Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation
Condition: Coronary Artery Disease
Intervention: Device: Qvanteq bioactive coronary stent
5 Completed
Has Results
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Conditions: Coronary Heart Disease;   Coronary Restenosis
Interventions: Drug: Oral sirolimus;   Device: Drug Eluting stent
6 Recruiting BES, EES, and ZES-R in Real World Practice
Condition: Coronary Artery Disease
Interventions: Device: Biolimus-eluting stent;   Device: Everolimus-eluting stent;   Device: Zotarolimus-eluting stent

Indicates status has not been verified in more than two years